ロード中...
Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
The main treatment for pemphigus vulgaris are systemic corticosteroids and immunosuppressive agents, but due to adverse reactions and therapeutic failure, new drugs such as rituximab and mycophenolate mofetil have been used. In this case report are described two cases of severe pemphigus vulgaris re...
保存先:
| 出版年: | An Bras Dermatol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Sociedade Brasileira de Dermatologia
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4230671/ https://ncbi.nlm.nih.gov/pubmed/25387507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20143128 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|